Next Article in Journal
Spatiotemporal Distribution and Genetic Characterization of Measles Strains Circulating in Greece during the 2017–2018 Outbreak
Next Article in Special Issue
Expression Pattern of the SARS-CoV-2 Entry Genes ACE2 and TMPRSS2 in the Respiratory Tract
Previous Article in Journal
Merkel Cell Polyomavirus Large T Antigen is Dispensable in G2 and M-Phase to Promote Proliferation of Merkel Cell Carcinoma Cells
Previous Article in Special Issue
Tracking SARS-CoV-2 in Sewage: Evidence of Changes in Virus Variant Predominance during COVID-19 Pandemic
viruses-logo
Article Menu

Article Menu

Open AccessArticle

Amplicon-Based Detection and Sequencing of SARS-CoV-2 in Nasopharyngeal Swabs from Patients With COVID-19 and Identification of Deletions in the Viral Genome That Encode Proteins Involved in Interferon Antagonism

1
Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L3 5RF, UK
2
College of Veterinary Medicine, Northwest A&F University, Yangling 712100, China
3
National Infection Service, Public Health England, Salisbury SP4 0JG, UK
4
Health Protection Research Unit in Emerging and Zoonotic Infections, Liverpool L69 7BE, UK
5
Liverpool Health Partners, Liverpool L3 5TF, UK
6
Tropical & Infectious Disease Unit, Liverpool University Hospitals NHS Foundation Trust (a member of Liverpool Health Partners), Liverpool L7 8XP, UK
7
Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK
8
School of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK
9
Laboratory Department, Directorate of Veterinary in Sulaimany, Rizgari 402, Sulaimani, Kurdistan Region 46001, Iraq
10
Research Center, King Fahad Medical City, Riyadh 11525, Saudi Arabia
11
The Peter Doherty Institute for Infection and Immunity, Melbourne 3000, Australia
12
Infectious Diseases Horizontal Technology Centre (ID HTC), A*STAR, Singapore 138648, Singapore
13
Faculty of Medicine, Imperial College London, London SW7 2AZ, UK
14
Roslin Institute, University of Edinburgh, Edinburgh EH25 9RG, UK
*
Authors to whom correspondence should be addressed.
These authors Contributed equally to this work.
Viruses 2020, 12(10), 1164; https://doi.org/10.3390/v12101164
Received: 8 September 2020 / Revised: 8 October 2020 / Accepted: 9 October 2020 / Published: 14 October 2020
(This article belongs to the Collection Coronaviruses)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19). Sequencing the viral genome as the outbreak progresses is important, particularly in the identification of emerging isolates with different pathogenic potential and to identify whether nucleotide changes in the genome will impair clinical diagnostic tools such as real-time PCR assays. Although single nucleotide polymorphisms and point mutations occur during the replication of coronaviruses, one of the biggest drivers in genetic change is recombination. This can manifest itself in insertions and/or deletions in the viral genome. Therefore, sequencing strategies that underpin molecular epidemiology and inform virus biology in patients should take these factors into account. A long amplicon/read length-based RT-PCR sequencing approach focused on the Oxford Nanopore MinION/GridION platforms was developed to identify and sequence the SARS-CoV-2 genome in samples from patients with or suspected of COVID-19. The protocol, termed Rapid Sequencing Long Amplicons (RSLAs) used random primers to generate cDNA from RNA purified from a sample from a patient, followed by single or multiplex PCRs to generate longer amplicons of the viral genome. The base protocol was used to identify SARS-CoV-2 in a variety of clinical samples and proved sensitive in identifying viral RNA in samples from patients that had been declared negative using other nucleic acid-based assays (false negative). Sequencing the amplicons revealed that a number of patients had a proportion of viral genomes with deletions. View Full-Text
Keywords: SARS-CoV-2; next-generation sequencing; amplicon; MinION SARS-CoV-2; next-generation sequencing; amplicon; MinION
Show Figures

Figure 1

MDPI and ACS Style

Moore, S.C.; Penrice-Randal, R.; Alruwaili, M.; Randle, N.; Armstrong, S.; Hartley, C.; Haldenby, S.; Dong, X.; Alrezaihi, A.; Almsaud, M.; Bentley, E.; Clark, J.; García-Dorival, I.; Gilmore, P.; Han, X.; Jones, B.; Luu, L.; Sharma, P.; Shawli, G.; Sun, Y.; Zhao, Q.; Pullan, S.T.; Carter, D.P.; Bewley, K.; Dunning, J.; Zhou, E.-M.; Solomon, T.; Beadsworth, M.; Cruise, J.; Crook, D.W.; Matthews, D.A.; Davidson, A.D.; Mahmood, Z.; Aljabr, W.; Druce, J.; Vipond, R.; Ng, L.; Renia, L.; Openshaw, P.J.M.; Baillie, J.K.; Carroll, M.W.; Stewart, J.; Darby, A.; Semple, M.; Turtle, L.; Hiscox, J.A. Amplicon-Based Detection and Sequencing of SARS-CoV-2 in Nasopharyngeal Swabs from Patients With COVID-19 and Identification of Deletions in the Viral Genome That Encode Proteins Involved in Interferon Antagonism. Viruses 2020, 12, 1164.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop